Stacey Pun, MD
Dermatopathology · Los Angeles, CANPI 1851763783
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,623 of the $2,921 with a category attached, or 89.8%. It is spread thinly across 20 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,329, more than ten times the $86 reported in 2021.
Across 129 payments — averaging $22.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$569
- Sanofi$349
- Incyte Corporation$308
- Sun Pharmaceutical Industries Inc.$247
- LEO Pharma Inc.$220
- Pfizer$196
- plus $1K from 14 others
What the payments were for
- Food & beverage$2,62390%
- Education$29810%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 23 | $569 |
| Sanofi | 11 | $349 |
| Incyte Corporation | 13 | $308 |
| Sun Pharmaceutical Industries Inc. | 9 | $247 |
| LEO Pharma Inc. | 12 | $220 |
| Pfizer | 13 | $196 |
| UCB, Inc. | 6 | $188 |
| Lilly USA, LLC | 6 | $161 |
| AbbVie | 7 | $147 |
| Amgen | 4 | $101 |
| Mayne Pharma Commercial LLC | 10 | $100 |
| Arcutis Biotherapeutics, Inc. | 3 | $59 |
| Botanix SB Inc | 2 | $51 |
| Novartis | 2 | $51 |
| Galderma Laboratories, L.p. | 2 | $39 |
| Almirall LLC | 2 | $37 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $33 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
| Verrica Pharmaceuticals Inc. | 1 | $22 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $20 |
How this compares
$2,921 in reported general payments places this provider in the 75th percentile of 76 dermatopathology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 30 | $1,543 |
| Betamethasone Dipropionate | 25 | $1,313 |
| Fluocinonide | 36 | $1,255 |
| Ketoconazole | 39 | $583 |
| Clindamycin Phosphate | 11 | $568 |
| Doxycycline Hyclate | 13 | $283 |
| Hydrocortisone | 36 | $190 |
| Mupirocin | 23 | $154 |
| Triamcinolone Acetonide | 21 | $143 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Los Angeles
- Brittney de ClerckLos Angeles$56K
- Emma TaylorLos Angeles$4K
- Joshua MoLos Angeles$811
- Honggang ShenLos Angeles$474
- Nima AminiLos Angeles$305
- Zachary GoldsteinLos Angeles$223
- Gene KimLos Angeles$187
- Lyndon SuLos Angeles$135
- Christiane QuerfeldDuarte$107K
- Brook Brouhala Jolla$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.